Insights into the management of pheochromocytoma and paraganglioma

Alfredo Berruti, MD, University of Brescia, Brescia, Italy, provides a succinct overview of the pathophysiology, comorbidities, and treatment options associated with advanced pheochromocytoma and paraganglioma. Prof. Berruti also stresses the necessity to improve on the targeted therapies currently at our disposal now that these tumors have been successfully divided into three molecular subtypes; pseudohypoxia, kinase-signaling, and Wnt altered. This interview took place at the ESMO Sarcoma and Rare Cancers Congress 2023 in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.